| Renal Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 142show all (up to 200) |
|---|
| → investigated in trials for | Nivolumabmonoclonal_antibody 115 trials (49 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 115 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall_molecule 112 trials (9 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 112 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 106 trials (46 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 106 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall_molecule 67 trials (39 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall_molecule 58 trials (21 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal_antibody 55 trials (6 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall_molecule 54 trials (4 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal_antibody 53 trials (29 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall_molecule 52 trials (4 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall_molecule 48 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall_molecule 30 trials (15 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belzutifansmall molecule 24 trials (19 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 22 trials (6 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 21 trials (9 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 20 trials (4 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 20 | Observed | clinicaltrials | graph → |